Materials & Resources » Chemical Industry » Bayer AG | Top pharmaceutical companies R&D spending share worldwide 2024

R&D spending share of top pharmaceutical companies 2017 and 2024

Top 20 pharmaceutical companies based on R&D spending as revenue share in 2017 and 2024

The data illustrates the top 20 pharmaceutical companies based on R&D spending as revenue share in 2017, and a forecast for 2024. Roche spent 22% of their prescription drug revenue on research and development in 2017 and is expected to increase the share to 23% in 2024.

Regeneron Pharmaceuticals 55.8 67.2
Eli Lilly 26.8 24.4
Roche 22 23
Boehringer Ingelheim 21.5 22.3
Merck & Co 21.4 21.8
Johnson & Johnson 24.3 21
Bayer 18.4 20
Bristol-Myers Squibb 25 19.9
Takeda 21.6 19.5
AstraZeneca 27.4 19.2
Astellas Pharma 21.5 18.9
Celgene 23.3 18.9
Sanofi 18.1 18.5
Gilead Sciences 13.7 18.3
Novartis 18.7 16.9
Amgen 16 16.5
GlaxoSmithKline 17.4 16.2
AbbVie 17.4 15.9
Pfizer 16.8 15.7
Novo Nordisk 12.5 12.6

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.